Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 4/20 | 0.55 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16211018 | 0.78 | ADORA1 (0.54) | ADORA1ADORA2BKDM4EALDH1A1HPGD | |
| SCHEMBL13853001 | 0.78 | L3MBTL1 (0.44) | KDM4EALDH1A1HPGDGAAHSD17B10 | |
| SCHEMBL13852964 | 0.74 | L3MBTL1 (0.42) | KDM4EALDH1A1HPGDGAAMEN1 | |
| SCHEMBL12799837 | 0.73 | ATM (0.53) | ADORA1ADORA2BKDM4EALDH1A1HPGD | |
| SCHEMBL26168133 | 0.72 | KDM4E (0.51) | KDM4EALDH1A1HPGDGAARXFP1 | |
| SCHEMBL4075651 | 0.72 | KDM4E (0.50) | KDM4EALDH1A1HPGDGAARXFP1 | |
| SCHEMBL9443489 | 0.71 | ADORA1 (0.46) | ADORA1ADORA2BKDM4EALDH1A1HPGD | |
| SCHEMBL21965199 | 0.70 | ADORA1 (0.44) | ADORA1ADORA2BKDM4EALDH1A1HPGD | |
| SCHEMBL822678 | 0.69 | PTGER1 (0.56) | ADORA2BKDM4EALDH1A1HPGDGAA | |
| SCHEMBL11516631 | 0.69 | KDM4E (0.51) | KDM4EALDH1A1HPGDGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389407-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230389407-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389407-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SNRPD2, HNRNPDL, SNRPA | ADORA1 1326/4885ADORA2B 742/4885KDM4E 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.